Skip to content

Mobility Optimization Through Velocity Exercise

Optimizing Mobility in Older Adults With Knee Osteoarthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00844558
Acronym
MOVE
Enrollment
58
Registered
2009-02-16
Start date
2008-08-31
Completion date
2011-10-31
Last updated
2016-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

osteoarthritis, knee pain, gait training, power training, rehabilitation, physical therapy

Brief summary

Knee Osteoarthritis (OA) accounts for a significant proportion of mobility limitations and is one of the most disabling problems facing the growing population of older adults. The purpose of this research is to reduce disablement of older adults with symptomatic knee osteoarthritis.

Detailed description

The long-term objective of this research is to reduce disablement of older adults with knee osteoarthritis (OA). This will be accomplished through assessing changes in functional limitations (standing and walking) that occur with 2 mobility-specific interventions. The principle of specificity of training indicates that exercises that closely approximate the goal functional activity are most effective in improving physical performance during that activity. However, there is uncertainty whether intervening to increase muscle power or to improve gait mechanics would be most effective for optimizing mobility in older adults with knee OA. Although gait training may be most specific for improving gait, this approach currently requires supervised physical therapy and expensive equipment. In contrast, power training may be less costly and more convenient if conducted at home. To optimize mobility in older adults with symptomatic knee OA, there is a need to study each of these mobility-specific interventions in a randomized controlled trial (RCT). Successful completion of this trial will inform rehabilitation for maintaining or improving mobility as well as explore the mechanism of effect. Specific Aim 1: Assess the efficacy of two innovative interventions for improving mobility limitations, disability and quality of life in older adults with symptomatic knee OA. Primary Hypothesis: For older adults with symptomatic knee OA, in comparison with usual care (control group), a 3-month a) patient-specific gait training intervention and b) mobility-specific power training intervention will reduce lower limb mobility limitations assessed using the Function component of the Late Life Function and Disability Index (LLFDI-Function). Hypothesis 2: Improved mobility will be maintained at 6 and 12-month follow-up (3 and 9 months following transitioning to home-based training) for each of the 2 intervention groups who receive the combination of the home-based intervention and encouragement to continue participation. Hypothesis 3: In comparison to baseline measures, at 3, 6, and 12-month follow-up, each of the 2 intervention groups will demonstrate improvements in a) disability (LDCW), b) quality of life assessed using the Knee Osteoarthritis Outcome Score questionnaire Quality of Life component(KOOS Knee QOL), and c) knee OA specific outcome scores using the pain subscale component of KOOS.

Interventions

OTHERGait Training

Gait training with a physical therapist 2/week for the first 3 months followed by 1/week for the following 3 months

OTHERControl

There is no intervention associated with this arm of the study

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
University of Iowa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 60 or older * Symptomatic knee osteoarthritis (knee osteoarthritis diagnosed by x-ray and frequent knee symptoms)

Exclusion criteria

* bilateral knee replacement * acute or terminal illness * unstable cardiovascular condition or other medical conditions that may impair ability to participate such as pulmonary disease requiring use of supplement oxygen, or current medical condition that affects walking, or lower limb musculoskeletal surgery in the past 6 months

Design outcomes

Primary

MeasureTime frameDescription
Change in Basic Lower Limb Function (Late Life Function Index) Late Life Function and Disability Instrument0,3,6, and 12 monthsThis is a questionnaire that evaluates self-reported difficulty in a person's ability to do discrete actions or activities primarily involving standing, stooping and fundamental walking activities without the help of others. Factors that may influence difficulty in task performance include pain, fatigue, fear, weakness, soreness, ailments, health conditions and disabilities. Scored from 14 to 70 with scores approaching 70 signifying high levels in ability to perform activities primarily involving standing, stooping, and fundamental walking (without assistance), and scores approaching 14 signifying low levels in ability to perform activities primarily involving standing, stooping, and fundamental walking (without assistance).

Secondary

MeasureTime frameDescription
Change in Knee Osteoarthritis Injury and Outcome Scale (KOOS) Pain0,3,6 and 12 monthsThis is a 42-item self-administered questionnaire that covers five patient-relevant dimensions, including pain and knee-related symptoms. This instrument has been found to be a reliable and responsive measure in older adults with knee OA as well as sensitive to changes in pain and knee-related symptoms over 6- and 12-mo periods. Scored from 0 to 100 with 100 indicating no pain.
Change in KOOS Symptoms0,3,6 and 12 monthsThis instrument has been found to be a reliable and responsive measure in older adults with knee OA as well as sensitive to changes in pain and knee-related symptoms over 6- and 12-mo periods. Scored from 0 to 100 with 100 indicating no symptoms.
Change in Long Distance Corridor Walk (LDCW) Time, Secs0,3,6 and 12 monthsThe LDCW included both 2-min walk distance and 400-m walk time. This measure has been shown to be predictive of changes in community mobility. Per the LDCW protocol, for participants unable to walk 400 m, gait speed was estimated from the 2-min walk distance, so that all participant data were on the same scale.
Change in Stair Climb Time, Secs0,3,6, and 12 monthsFunctional limitations specific to ascending stairs were assessed with a times stair climb, using a standard eight-stair flight (stair height = 19 cm)
Change in Chair Stand Time0,3,6,and 12 monthsMeasured as the total time (in seconds) required to stand five times from a seated position in a standardized chair without using arms.

Countries

United States

Participant flow

Participants by arm

ArmCount
Gait
The gait participants were randomized and attended 24 biweekly 45-minute sessions directed by a physical therapist, which were composed of guided strategies to optimize knee movements during treadmill walking, using computerized motion analysis with visual biofeedback.
36
Control
The control participants received their usual care for symptomatic knee osteoarthritis (OA) through their usual healthcare providers and were not asked to make changes to their lifestyle.Usual care for these subjects may have included a yearly visit with their physician, use of pain medications for knee symptoms, knee surgery, and/or physical therapy.
22
Total58

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath10
Overall StudyLost to Follow-up01
Overall StudyPhysician Decision10
Overall StudyProtocol Violation11
Overall StudyWithdrawal by Subject92

Baseline characteristics

CharacteristicGaitControlTotal
Age, Continuous69.1 years
STANDARD_DEVIATION 7.3
69.6 years
STANDARD_DEVIATION 6.4
69.3 years
STANDARD_DEVIATION 7.35
Region of Enrollment
United States
36 participants22 participants58 participants
Sex: Female, Male
Female
22 Participants10 Participants32 Participants
Sex: Female, Male
Male
14 Participants12 Participants26 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 360 / 22
serious
Total, serious adverse events
0 / 360 / 22

Outcome results

Primary

Change in Basic Lower Limb Function (Late Life Function Index) Late Life Function and Disability Instrument

This is a questionnaire that evaluates self-reported difficulty in a person's ability to do discrete actions or activities primarily involving standing, stooping and fundamental walking activities without the help of others. Factors that may influence difficulty in task performance include pain, fatigue, fear, weakness, soreness, ailments, health conditions and disabilities. Scored from 14 to 70 with scores approaching 70 signifying high levels in ability to perform activities primarily involving standing, stooping, and fundamental walking (without assistance), and scores approaching 14 signifying low levels in ability to perform activities primarily involving standing, stooping, and fundamental walking (without assistance).

Time frame: 0,3,6, and 12 months

ArmMeasureGroupValue (MEAN)
GaitChange in Basic Lower Limb Function (Late Life Function Index) Late Life Function and Disability InstrumentChange from baseline to month 33.3 units on a scale
GaitChange in Basic Lower Limb Function (Late Life Function Index) Late Life Function and Disability InstrumentChange from baseline to month 63.1 units on a scale
GaitChange in Basic Lower Limb Function (Late Life Function Index) Late Life Function and Disability InstrumentChange from baseline to month 123.9 units on a scale
Control GroupChange in Basic Lower Limb Function (Late Life Function Index) Late Life Function and Disability InstrumentChange from baseline to month 3-1.0 units on a scale
Control GroupChange in Basic Lower Limb Function (Late Life Function Index) Late Life Function and Disability InstrumentChange from baseline to month 60.8 units on a scale
Control GroupChange in Basic Lower Limb Function (Late Life Function Index) Late Life Function and Disability InstrumentChange from baseline to month 122.9 units on a scale
Secondary

Change in Chair Stand Time

Measured as the total time (in seconds) required to stand five times from a seated position in a standardized chair without using arms.

Time frame: 0,3,6,and 12 months

ArmMeasureGroupValue (MEAN)
GaitChange in Chair Stand TimeChange from baseline to month 3-0.9 seconds
GaitChange in Chair Stand TimeChange from baseline to month 6-1.9 seconds
GaitChange in Chair Stand TimeChange from baseline to month 12-2.5 seconds
Control GroupChange in Chair Stand TimeChange from baseline to month 3-1.0 seconds
Control GroupChange in Chair Stand TimeChange from baseline to month 6-3.0 seconds
Control GroupChange in Chair Stand TimeChange from baseline to month 12-2.9 seconds
Secondary

Change in Knee Osteoarthritis Injury and Outcome Scale (KOOS) Pain

This is a 42-item self-administered questionnaire that covers five patient-relevant dimensions, including pain and knee-related symptoms. This instrument has been found to be a reliable and responsive measure in older adults with knee OA as well as sensitive to changes in pain and knee-related symptoms over 6- and 12-mo periods. Scored from 0 to 100 with 100 indicating no pain.

Time frame: 0,3,6 and 12 months

ArmMeasureGroupValue (MEAN)
GaitChange in Knee Osteoarthritis Injury and Outcome Scale (KOOS) PainChange from baseline to month 38.2 units on a scale
GaitChange in Knee Osteoarthritis Injury and Outcome Scale (KOOS) PainChange from baseline to month 65.4 units on a scale
GaitChange in Knee Osteoarthritis Injury and Outcome Scale (KOOS) PainChange from baseline to month 1210.1 units on a scale
Control GroupChange in Knee Osteoarthritis Injury and Outcome Scale (KOOS) PainChange from baseline to month 31.1 units on a scale
Control GroupChange in Knee Osteoarthritis Injury and Outcome Scale (KOOS) PainChange from baseline to month 61.7 units on a scale
Control GroupChange in Knee Osteoarthritis Injury and Outcome Scale (KOOS) PainChange from baseline to month 122.8 units on a scale
Secondary

Change in KOOS Symptoms

This instrument has been found to be a reliable and responsive measure in older adults with knee OA as well as sensitive to changes in pain and knee-related symptoms over 6- and 12-mo periods. Scored from 0 to 100 with 100 indicating no symptoms.

Time frame: 0,3,6 and 12 months

ArmMeasureGroupValue (MEAN)
GaitChange in KOOS SymptomsChange from baseline to month 311.5 units on a scale
GaitChange in KOOS SymptomsChange from baseline to month 68.1 units on a scale
GaitChange in KOOS SymptomsChange from baseline to month 128.5 units on a scale
Control GroupChange in KOOS SymptomsChange from baseline to month 33.0 units on a scale
Control GroupChange in KOOS SymptomsChange from baseline to month 61.8 units on a scale
Control GroupChange in KOOS SymptomsChange from baseline to month 122.4 units on a scale
Secondary

Change in Long Distance Corridor Walk (LDCW) Time, Secs

The LDCW included both 2-min walk distance and 400-m walk time. This measure has been shown to be predictive of changes in community mobility. Per the LDCW protocol, for participants unable to walk 400 m, gait speed was estimated from the 2-min walk distance, so that all participant data were on the same scale.

Time frame: 0,3,6 and 12 months

ArmMeasureGroupValue (MEAN)
GaitChange in Long Distance Corridor Walk (LDCW) Time, SecsChange from baseline to month 311.5 seconds
GaitChange in Long Distance Corridor Walk (LDCW) Time, SecsChange from baseline to month 68.1 seconds
GaitChange in Long Distance Corridor Walk (LDCW) Time, SecsChange from baseline to month 128.5 seconds
Control GroupChange in Long Distance Corridor Walk (LDCW) Time, SecsChange from baseline to month 33.0 seconds
Control GroupChange in Long Distance Corridor Walk (LDCW) Time, SecsChange from baseline to month 61.8 seconds
Control GroupChange in Long Distance Corridor Walk (LDCW) Time, SecsChange from baseline to month 122.4 seconds
Secondary

Change in Stair Climb Time, Secs

Functional limitations specific to ascending stairs were assessed with a times stair climb, using a standard eight-stair flight (stair height = 19 cm)

Time frame: 0,3,6, and 12 months

ArmMeasureGroupValue (MEAN)
GaitChange in Stair Climb Time, SecsChange from baseline to month 30.2 seconds
GaitChange in Stair Climb Time, SecsChange from baseline to month 6-0.2 seconds
GaitChange in Stair Climb Time, SecsChange from baseline to month 12-0.3 seconds
Control GroupChange in Stair Climb Time, SecsChange from baseline to month 30.0 seconds
Control GroupChange in Stair Climb Time, SecsChange from baseline to month 6-1.4 seconds
Control GroupChange in Stair Climb Time, SecsChange from baseline to month 12-1.1 seconds

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026